Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
HIV Med. 2023 Feb;24(2):107-110. doi: 10.1111/hiv.13427. Epub 2022 Nov 23.
The World Health Organization's (WHO's) new global health strategy on HIV represents a major step toward a broader conceptualization of HIV care. It recognizes the importance of addressing chronic care more fully and-for the first time ever-the health-related quality of life (HRQoL) of people living with HIV (PLHIV).
A thorough literature review was conducted in order to analyse how the WHO strategy on HIV for 2022-2030 addresses the monitoring of the HRQoL of PLHIV for the next decade and compared it to that of other countries and health authorities.
Unlike for other issues, the strategy does not include quantitative targets for 2030, thus falling short of committing to monitoring global progress in improving the long-term well-being of PLHIV.
We urge national health systems not to wait for WHO to lead on this issue. Seeking good HRQoL outcomes for PLHIV can confer far-reaching benefits on health systems. The feasibility of monitoring population-level HRQoL has been demonstrated through the use of simple tools like patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). Many countries can already set HRQoL monitoring targets, similar to those presented in this viewpoint, while we work toward an agreed minimum metric for use by all countries.
世界卫生组织(WHO)新的全球艾滋病毒战略代表着朝着更全面的艾滋病毒护理概念迈出的重要一步。它认识到更全面地解决慢性病问题的重要性,并且首次关注艾滋病毒感染者(PLHIV)的健康相关生活质量(HRQoL)。
为了分析 2022-2030 年 WHO 艾滋病毒战略如何为未来十年监测 PLHIV 的 HRQoL 提供信息,并将其与其他国家和卫生当局进行比较,我们进行了全面的文献综述。
与其他问题不同,该战略未为 2030 年设定定量目标,因此未能承诺监测改善 PLHIV 长期福祉方面的全球进展。
我们敦促国家卫生系统不要等待世卫组织在这个问题上发挥领导作用。寻求 PLHIV 的良好 HRQoL 结果可以为卫生系统带来深远的好处。通过使用简单的工具,如患者报告的结果测量(PROMs)和患者报告的体验测量(PREMs),已经证明了监测人群水平 HRQoL 的可行性。许多国家已经可以设定 HRQoL 监测目标,类似于本观点中提出的目标,同时我们致力于为所有国家商定一个最低通用指标。